In Brief: Acetaminophen Warnings, OTC HSA Bill, Durbin’s Supplement Reg Bill
This article was originally published in The Tan Sheet
Executive Summary
FDA adds acetaminophen warnings; CHPA suggests 4-aminophenol standard; OTC HSA bill in House; supplement registration bill reintroduced; FSMA user fees still on hold; more scrutiny of energy drinks; and Public Citizen pans OTC Oxytrol.
You may also be interested in...
Guidance On Acetaminophen Allergy Warning Trails Industry's Change
Final US guidance adds CHPA's suggestion for an example for a warning on labeling for products containing both acetaminophen and aspirin, needed to highlight where “Allergy Alert” and “Liver Warning” statements are on those products' labels.
Guidance On Acetaminophen Allergy Warning Trails Industry's Change
Final US guidance adds CHPA's suggestion for an example for a warning on labeling for products containing both acetaminophen and aspirin, needed to highlight where “Allergy Alert” and “Liver Warning” statements are on those products' labels.
Durbin’s DoD Supplement Proposal Could Be ‘Back Door’ To Pre-market Approval Rule
The Illinois senator proposes an amendment to the National Defense Authorization Act that would require third-party verification for supplements sold at any commissary or other retail store operating on a DoD installation.